ProQR Therapeutics (PRQR) Non-Current Assets (2021 - 2024)
Historic Non-Current Assets for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $15.1 million.
- ProQR Therapeutics' Non-Current Assets fell 1704.64% to $15.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $15.1 million, marking a year-over-year decrease of 1704.64%. This contributed to the annual value of $15.3 million for FY2024, which is 1642.84% down from last year.
- According to the latest figures from Q4 2024, ProQR Therapeutics' Non-Current Assets is $15.1 million, which was down 1704.64% from $18.2 million recorded in Q4 2023.
- ProQR Therapeutics' 5-year Non-Current Assets high stood at $110.5 billion for Q1 2021, and its period low was $15.1 million during Q4 2024.
- Over the past 4 years, ProQR Therapeutics' median Non-Current Assets value was $18.9 million (recorded in 2023), while the average stood at $8.5 billion.
- As far as peak fluctuations go, ProQR Therapeutics' Non-Current Assets tumbled by 9998.2% in 2022, and later soared by 624.47% in 2023.
- Quarter analysis of 4 years shows ProQR Therapeutics' Non-Current Assets stood at $20.7 million in 2021, then dropped by 16.9% to $17.2 million in 2022, then rose by 5.68% to $18.2 million in 2023, then dropped by 17.05% to $15.1 million in 2024.
- Its last three reported values are $15.1 million in Q4 2024, $18.2 million for Q4 2023, and $18.9 million during Q3 2023.